Latest Ratios: P/E Ratio N/A · EV/EBITDA N/A · ROE N/A. (2026–2026 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM |
|---|---|
| Market Cap | — |
| Enterprise Value | — |
| P/E Ratio → | — |
| P/S Ratio | — |
| P/B Ratio | — |
| P/FCF | — |
| P/OCF | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM |
|---|---|
| EV / Revenue | — |
| EV / EBITDA | — |
| EV / EBIT | — |
| EV / FCF | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM |
|---|---|
| Gross Margin | — |
| Operating Margin | — |
| Net Profit Margin | — |
| Metric | TTM |
|---|---|
| ROE | — |
| ROA | — |
| ROIC | — |
| ROCE | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM |
|---|---|
| Debt / Equity | — |
| Debt / EBITDA | — |
| Net Debt / Equity | — |
| Net Debt / EBITDA | — |
| Debt / FCF | — |
| Interest Coverage | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM |
|---|---|
| Current Ratio | — |
| Quick Ratio | — |
| Cash Ratio | — |
| Asset Turnover | — |
| Inventory Turnover | — |
| Days Sales Outstanding | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM |
|---|---|
| Dividend Yield | — |
| Payout Ratio | — |
| Metric | TTM |
|---|---|
| Earnings Yield | — |
| FCF Yield | — |
| Buyback Yield | — |
| Total Shareholder Yield | — |
| Shares Outstanding | — |
Mega-cap equity concentration
According to market pricing data, QQQ maintains a valuation premium relative to lower-cost alternatives like QQQM, suggesting that investors are willing to pay for superior secondary market liquidity and options depth rather than purely for the underlying index exposure provided by the trust's current asset holdings.
The valuation of the trust is effectively a reflection of the market's willingness to pay for the infrastructure of price discovery. This premium appears to be a structural feature of the product's dominance in institutional trading, rather than a reflection of the underlying growth rate of the Nasdaq-100 constituents.
As reported in the trust's prospectus, the 0.20% expense ratio provides a highly predictable revenue stream that scales with AUM, resulting in strong operating margins that are largely insulated from the operational overhead typically associated with active management or traditional corporate business models in the financial sector.
The profitability of the trust is essentially a function of its scale, as the fixed costs of index licensing and trustee fees do not rise linearly with assets. This suggests that the sponsor captures significant operating leverage, provided that the trust maintains its status as the primary vehicle for Nasdaq-100 exposure.
Based on the trust's operational framework, efficiency is defined by the minimal tracking error and the ability to manage large-scale inflows without significant slippage, which distinguishes the trust's performance from less liquid index-tracking vehicles that may struggle with the execution of large rebalancing trades during market volatility.
The trust's efficiency is not measured by traditional working capital metrics, but by its ability to mirror the Nasdaq-100 index with minimal deviation. Investors should monitor whether rebalancing slippage increases as the trust's AUM grows, as this could eventually impact the net returns delivered to shareholders.
Market participants frequently misapply traditional technology sector valuation multiples to QQQ, which obscures the fact that the trust is a diversified proxy for the 'New Economy' rather than a pure-play technology fund, according to an analysis of the trust's sector composition and its underlying index methodology.
Treating the trust as a pure technology play may lead to an underestimation of risks related to consumer discretionary and healthcare sectors. Analysts should instead focus on the concentration ratio of the top ten holdings, as this metric provides a more accurate assessment of the trust's idiosyncratic risk profile than sector-based valuation multiples.
Includes 30+ ratios · 0 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying QQQ stock.
Based on historical data, Invesco QQQ Trust is trading at valuation metrics that vary. Compare with industry peers and growth rates for a complete picture.